Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGynecological OncologyradiotherapyDiseaseCervical CancerSubgroupICD10C53.-MeSHUterine Cervical NeoplasmsSequencePACL135/CISP30/Radiation, Cervical Ca (PID1990)ChemotherapyChemo-substanceCarboplatinCisplatinGemcitabinePaclitaxelChemo-substanceCarboplatinCisplatinGemcitabinePaclitaxelChemo-substanceCarboplatinCisplatinGemcitabinePaclitaxelChemo-substanceCarboplatinCisplatinGemcitabinePaclitaxelNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesium sulfatePotassium chlorideNo. Substances2368Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativepalliativeRisksAbdominal PainAlopeciaAnemia Hb below 8g/dlAnorexiaArthalgiaConstipationCystitisDiarrheaEmetogenicity (MASCC/ESMO)Hand-Foot SyndromeIncrease AminotransferasesLeukopeniaMyalgiasNeuropathyNeutropeniaOral MucositisRashThrombocytopenia below 50 000/µlThromboembolic EventVomiting only studiesPublicationAuthorHuang HKatanyoo KPattaranutaporn PSehouli JDiseasefortgeschrittenes Zervixkarzinom, Stadium IIb-IVaZervix Ca, FIGO IB1, IB2, IIA1, IIA2, nach Hysterektomie und pelviner LymphadenektomieZervixkarzinom (Plattenepithel-), FIGO IIIB, keine Vortherapie, ECOG 0-2Zervixkarzinom, FIGO Stadium IB2-IIB oder IBI + Risikofaktoren, nach radikaler HysterektomieOriginCollaborative Innovation Center for Cancer Medicine, Guangzhou, China, STARS trialDepartment of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, ThailandDivision of Radiation Oncology, Mahidol University, Bangkok, 10700, ThailandNOGGO-AGOProtocols in Revision 5 protocols foundProtocols under revision.Carboplatin 2 / Radiation, Cervical Cancer (PID1939 V1.0)Cisplatin 40 / Radiation, Cervical Cancer Adjuvant (PID540 V1.2)Gemcitabine 300 / Radiation, Cervical Cancer (PID2604 V1.0)Paclitaxel 135 / Cisplatin 30 / Radiation, Cervical Carcinoma (PID1990 V1.1)Paclitaxel 175 / Carboplatin 5 followed by Radiation, Cervical Cancer adjuvant (PID97 V1.1)
